Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,533 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,899 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03809000 | A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery(STEEL) | active not recruiting | Phase 2 | 188 | RTOG Foundation, Inc.OTHER | 2 | Dec 30, 2025 | clinicaltrials |
| NCT07292337 | AcuTENS for Pain Relief During TRUS-Guided Prostate Biopsy | active not recruiting | N/A | 53 | University of MalayaOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT04655365 | Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer.(PROSTEP-002) | active not recruiting | Phase 2 | 50 | CHU de Quebec-Universite LavalOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT06822491 | Early Magnetic Resonance Imaging Response of the Dominant Intraprostatic Lesion After Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer and Correlation With Prostate Specific Antigen Response(PRODART) | active not recruiting | — | 28 | University of ZurichOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT06229366 | [Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer(ACCEL) | active not recruiting | Phase 1 | 142 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 22, 2025 | clinicaltrials |
| NCT02452008 | Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer | active not recruiting | Phase 2 | 60 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT03753334 | Effects of EPA in Men With Biochemical Recurrence or Progression of Prostate Cancer.(RCT-EPAII-BCR) | active not recruiting | Phase 2 | 39 | CHU de Quebec-Universite LavalOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT04446117 | Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC(CONTACT-02) | active not recruiting | Phase 3 | 575 | ExelixisINDUSTRY | 27 | Dec 18, 2025 | clinicaltrials |
| NCT00937586 | Prostate Cancer Prospective Cohort | active not recruiting | — | 1,937 | Washington University School of MedicineOTHER | 1 | Dec 17, 2025 | clinicaltrials |
| NCT06397651 | A Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live CoActive Exercise Coaching and Personalized Digital Application on Cancer Survivors' Quality of Life | active not recruiting | N/A | 146 | Complement Theory Inc.INDUSTRY | 1 | Dec 17, 2025 | clinicaltrials |
| NCT04025372 | INTREPId (INTermediate Risk Erection PreservatIon Trial) | active not recruiting | Phase 2 | 234 | Brigham and Women's HospitalOTHER | 1 | Dec 15, 2025 | clinicaltrials |
| NCT06105918 | Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer | active not recruiting | Phase 1 | 6 | Emory UniversityOTHER | 1 | Dec 9, 2025 | clinicaltrials |
| NCT03511196 | Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer | active not recruiting | Early Phase 1 | 17 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT04319146 | Study of Robot-assisted Radical Prostatectomy Performed on Outpatient in Patients With Localized Prostate Cancer(AMBUPRO) | active not recruiting | N/A | 20 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT05189457 | First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer | active not recruiting | Phase 2 | 32 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT07265414 | DRG Mutations in Prostate Cancer: a Guiding Light for Enhanced Screening and Personalised Therapy | active not recruiting | — | 320 | Istituto Clinico HumanitasOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT07262073 | Comparison of Peak Expiratory Flow Changes After Robot-Assisted Versus Open Radical Prostatectomy | active not recruiting | N/A | 60 | Ankara City Hospital BilkentOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT02341989 | Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer(SWENOTECA-ABC) | active not recruiting | Phase 3 | 348 | St. Olavs HospitalOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT01607008 | MRI for Assessing Prostate Cancer Response(NA_00067284) | active not recruiting | N/A | 38 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Nov 28, 2025 | clinicaltrials |
| NCT03983954 | Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer. | active not recruiting | Phase 1 | 120 | NeoTX Therapeutics Ltd.INDUSTRY | 2 | Nov 28, 2025 | clinicaltrials |
| NCT03143322 | Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases(STEREO-OS) | active not recruiting | N/A | 168 | UNICANCEROTHER | 1 | Nov 26, 2025 | clinicaltrials |
| NCT02023463 | Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer | active not recruiting | Phase 1 | 25 | Thomas Jefferson UniversityOTHER | 1 | Nov 25, 2025 | clinicaltrials |
| NCT05696444 | Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO) | active not recruiting | N/A | 144 | Medtronic - MITGINDUSTRY | 1 | Nov 25, 2025 | clinicaltrials |
| NCT01653925 | Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression | active not recruiting | N/A | 120 | CHU de Quebec-Universite LavalOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT05238883 | A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors | active not recruiting | Phase 1 | 72 | HiFiBiO TherapeuticsINDUSTRY | 2 | Nov 21, 2025 | clinicaltrials |
| NCT02333435 | Effects of EPA on Prostate Cancer Cells Proliferation and Quality of Life(RCT-EPA) | active not recruiting | Phase 2 | 130 | CHU de Quebec-Universite LavalOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT03912883 | Prognostic Factors in Prostate Cancer for Patients Treated by Watchful Waiting(TAPG) | active not recruiting | — | 3,350 | Queen Mary University of LondonOTHER | 0 | Nov 18, 2025 | clinicaltrials |
| NCT02339701 | Stereotactic Body Radiotherapy vs Intensity-modulated Radiotherapy in Prostate Cancer | active not recruiting | N/A | 68 | Chinese University of Hong KongOTHER | 1 | Nov 17, 2025 | clinicaltrials |
| NCT05973487 | A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors | active not recruiting | Phase 1 | 840 | TScan Therapeutics, Inc.INDUSTRY | 1 | Nov 17, 2025 | clinicaltrials |
| NCT06733337 | A Study to Learn About the Safety of TALZENNA in People With Prostate Cancer. | active not recruiting | — | 1 | PfizerINDUSTRY | 1 | Nov 17, 2025 | clinicaltrials |
| NCT02735252 | PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer | active not recruiting | N/A | 156 | University of California, San FranciscoOTHER | 1 | Nov 12, 2025 | clinicaltrials |
| NCT03582475 | Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate | active not recruiting | Phase 1 | 15 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Nov 12, 2025 | clinicaltrials |
| NCT03541850 | Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery | active not recruiting | Phase 2 | 92 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Nov 6, 2025 | clinicaltrials |
| NCT04349501 | Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI)(ProsRSI) | active not recruiting | N/A | 100 | University of California, San DiegoOTHER | 1 | Nov 5, 2025 | clinicaltrials |
| NCT06479187 | PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer | active not recruiting | Phase 4 | 20 | Brigham and Women's HospitalOTHER | 1 | Nov 5, 2025 | clinicaltrials |
| NCT05100472 | A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer | active not recruiting | Phase 2 | 50 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 4, 2025 | clinicaltrials |
| NCT05779943 | Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer | active not recruiting | Phase 2 | 20 | Emory UniversityOTHER | 1 | Oct 27, 2025 | clinicaltrials |
| NCT01794403 | Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer(HEAT) | active not recruiting | N/A | 161 | University of MiamiOTHER | 3 | Oct 24, 2025 | clinicaltrials |
| NCT01514669 | Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer | active not recruiting | — | 75 | University of ArkansasOTHER | 1 | Oct 10, 2025 | clinicaltrials |
| NCT05540392 | An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues | active not recruiting | Phase 1 / Phase 2 | 60 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 10, 2025 | clinicaltrials |
| NCT05540782 | A Study of Cognitive Health in Survivors of Prostate Cancer | active not recruiting | — | 200 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 9, 2025 | clinicaltrials |
| NCT02917798 | Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes | active not recruiting | — | 1,047 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 7, 2025 | clinicaltrials |
| NCT07207902 | Surveillance or Focal Therapy(SOFT) | active not recruiting | N/A | 400 | Kaiser PermanenteOTHER | 1 | Oct 6, 2025 | clinicaltrials |
| NCT00261456 | The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer | active not recruiting | — | 3,500 | Institute of Cancer Research, United KingdomOTHER | 1 | Sep 26, 2025 | clinicaltrials |
| NCT03158922 | The BARCODE 1 Pilot Study(BARCODE1Pilot) | active not recruiting | — | 329 | Institute of Cancer Research, United KingdomOTHER | 1 | Sep 26, 2025 | clinicaltrials |
| NCT03814252 | Prospective Clinical Safety and Efficacy Study of Lesion-targeted MRI-TULSA for Localized Prostate Cancer(PRO-TULSA-PC) | active not recruiting | N/A | 62 | Turku University HospitalOTHER_GOV | 1 | Sep 22, 2025 | clinicaltrials |
| NCT02194842 | Phase III Radium 223 mCRPC-PEACE III(PEACE III) | active not recruiting | Phase 3 | 446 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Sep 19, 2025 | clinicaltrials |
| NCT02972060 | ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer | active not recruiting | Phase 2 | 61 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 4 | Sep 19, 2025 | clinicaltrials |
| NCT04763915 | Improving Care After Inherited Cancer Testing(IMPACT) | active not recruiting | N/A | 720 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Sep 19, 2025 | clinicaltrials |
| NCT05354440 | Post Marketing Clinical Follow Up of the BioProtect Balloon Implant System(CLP-10441) | active not recruiting | — | 80 | BioProtectINDUSTRY | 5 | Sep 19, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Dec 30, 2025source: clinicaltrials